Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-09-19

Clinical Trial Update: Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for alcohol withdrawal syndrome using adjunctive phenobarbital or ketamine; study withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)
  • Phenobarbital (phenobarbital)

Snippet

Sponsor: Santa Barbara Cottage Hospital | Conditions: Alcohol Withdrawal Syndrome | Phase 4 | Status: WITHDRAWN